China, Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer Research Report 2015 to 2021
Description-
The
global Drugs for Treatment of Prostate
Cancer
market was valued at USD 30.41 Billion in 2015, and is projected to
reach USD 35.26 Billion by 2021, at a CAGR of 59.49% between 2016 and
2021. The market is projected witness significant growth in the
coming years, owing to the aging population increase, increased
incidence and development of new drugs
This
report studies Drugs for Treatment of Prostate Cancer in China,
Russia, Brazil and Japan market, including Triptorelin, Leuprorelin,
Flutamide Tablets, Goserelin, Bicalutamide Tablets, Bicalutamide
Capsules, Estramustine Phosphate Capsules, Mitoxantrone, Zytiga and
Xtandi, focuses on price, sales, revenue of each type in global. This
report also focuses on the sales (consumption), production, import
and export of Drugs for Treatment of Prostate Cancer forecast to
2021, from 2015.
To
Browse a Report Detail with TOC @
http://www.researchmoz.us/china-russia-brazil-and-japan-drugs-for-treatment-of-prostate-cancer-research-report-2015-to-2021-report.html
On
basis of segments by Types, this report focuses on price, sales,
revenue and growth rate of each type, as well as the types and each
type price of key manufacturers, through interviewing key
manufacturers.
On
basis of segments by manufacturers, this report focuses on the sales,
price of each type, average price of Drugs for Treatment of Prostate
Cancer, revenue and market share, for key manufacturers. The main
manufacturers as follows: IPSEN, Ferring Pharmaceuticals, Takeda
Pharmaceutical Company Limited, Schering-Plough Canada,
S.C.SINDAN-PHARMA S.R.L., AstraZeneca, Corden Pharma GmbH, Shanxi
Zhendong Pharmaceutical, Pfizer, Johnson, Astellas and so on.
On
basis of segments by regions, this report focuses on the sales
(consumption), production, import and export of Drugs for Treatment
of Prostate Cancer in America, Established ROW, Western Europe,
Emerging Markets, Russia and China.
On
basis of segments by applications, this report focuses on consumption
and growth rate of Drugs for Treatment of Prostate Cancer in major
applications.
With
220ges, 231 charts and eight chapters, to display the market present
situation and future, clearly and deeply.
Table
of Contents
China,
Russia, Brazil and Japan Drugs for Treatment of Prostate Cancer
Research Report 2015 to 2021
1
Drugs for Treatment of Prostate Cancer Overview and Each Type
1.1
Product Overview of Prostate Cancer
1.1.1
Definition and Product Scope of Drugs for Prostate Cancer
1.1.2
China Market Size (Value and Volume) of Drugs for Prostate Cancer
2016-2021
1.1.3
Russia Market Size (Value and Volume) of Drugs for Prostate Cancer
2016-2021
1.1.4
Brazil Market Size (Value and Volume) of Drugs for Prostate Cancer
2016-2021
1.1.5
Japan Market Size (Value and Volume) of Drugs for Prostate Cancer
2016-2021
1.2
Product Segments and Price of Each Type
1.2.1
Product Type of Key Manufacturers
1.2.2
Price List and of Each Type 2015 to 2016
1.2.3
Market Share and Growth Rate of Each Type
1.2.4
Triptorelin and Specification
1.2.5
Leuprorelin and Specification
1.2.6
Flutamide Tablets and Specification
1.2.7
Goserelin and Specification
1.2.8
Bicalutamide Tablets and Specification
1.2.9
Bicalutamide Capsules and Specification
1.2.10
Estramustine Phosphate Capsules and Specification
1.2.11
Mitoxantrone and Specification
1.2.12
Zytiga and Specification
1.2.13
Xtandi and Specification
1.3
Price List (Interviewed) of Each Type for Manufacturers 2015 and 2016
1.3.1
Price List (Interviewed) of Triptorelin by Manufacturers
1.3.2
Price List (Interviewed) of Leuprorelin by Key Manufacturers
1.3.3
Price List (Interviewed) of Flutamide Tablets by Manufacturers
1.3.4
Price List (Interviewed) of Goserelin by Manufacturers
1.3.5
Price List (Interviewed) of Bicalutamide Tablets by Manufacturers
1.3.6
Price List (Interviewed) of Bicalutamide Capsules by Manufacturers
1.3.7
Price List (Interviewed) of Estramustine Phosphate Capsules by
Manufacturers
1.3.8
Price List (Interviewed) of Mitoxantrone by Manufacturers
1.3.9
Price List (Interviewed) of Zytiga by Manufacturers
1.3.10
Price List (Interviewed) of Xtandi by Manufacturers
2
Competition Analysis by Manufacturers in Global and China
2.1
Market Drugs for Treatment of Prostate Cancer Sales and Share List of
Key Manufacturers 2015 to 2016
2.2
China Market Drugs for Treatment of Prostate Cancer Sales and Share
List of Key Manufacturers 2010 to 2015
2.3
China Market Drugs for Treatment of Prostate Cancer Revenue and Share
List of Key Manufacturers 2010 to 2015
2.4
China Drugs for Treatment of Prostate Cancer Average Price List of
Key Manufacturers 2015 to 2016
2.5
Russia Market Drugs for Treatment of Prostate Cancer Sales and Share
List of Key Manufacturers 2010 to 2015
2.6
Russia Market Drugs for Treatment of Prostate Cancer Revenue and
Share List of Key Manufacturers 2010 to 2015
2.7
Russia Drugs for Treatment of Prostate Cancer Average Price List of
Key Manufacturers 2015 to 2016
2.8
Brazil Market Drugs for Treatment of Prostate Cancer Sales and Share
List of Key Manufacturers 2010 to 2015
2.9
Brazil Market Drugs for Treatment of Prostate Cancer Revenue and
Share List of Key Manufacturers 2010 to 2015
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment